Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 657-661

  Dennehy, Kevin M ^a   Klimosch, Sascha N ^b   Steinle, Alexander ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKP80; PHOSPHOPEPTIDE; PROTEIN KINASE LCK; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CELL STRAIN; CELL STRAIN NK92MI; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; GENE MUTATION; HEMI ITAM; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOICHIOMETRY;

AMINO ACID MOTIFS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PHOSPHOPEPTIDES; PROTEIN-TYROSINE KINASES; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

EID: 79251564072     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904117     Document Type: Article

References (18)

1. MacFarlane, A. W., IV, and K. S. Campbell. 2006. Signal transduction in natural killer cells. Curr. Top. Microbiol. Immunol. 298: 23-57.
2. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
3. Vitale, M., M. Falco, R. Castriconi, S. Parolini, R. Zambello, G. Semenzato, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2001. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31: 233-242.
4. Kuttruff, S., S. Koch, A. Kelp, G. Pawelec, H. G. Rammensee, and A. Steinle. 2009. NKp80 defines and stimulates a reactive subset of CD8 T cells. Blood 113: 358-369.
5. Welte, S., S. Kuttruff, I. Waldhauer, and A. Steinle. 2006. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7: 1334-1342.
6. Fuller, G. L., J. A. Williams, M. G. Tomlinson, J. A. Eble, S. L. Hanna S. Pöhlmann, K. Suzuki-Inoue, Y. Ozaki, S. P. Watson, and A. C. Pearce. 2007. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J. Biol. Chem. 282: 12397-12409.
7. Robinson, M. J., D. Sancho, E. C. Slack, S. LeibundGut-Landmann, and C. Reis e Sousa. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7: 1258-1265.
8. Huysamen, C., J. A. Willment, K. M. Dennehy, and G. D. Brown. 2008. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J. Biol. Chem. 283: 16693-16701.
9. Braselmann, S., V. Taylor, H. Zhao, S. Wang, C. Sylvain, M. Baluom, K. Qu E. Herlaar, A. Lau, C. Young, et al. 2006. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J. Pharmacol. Exp. Ther. 319: 998-1008.
10. Kitamura, T. 1998. New experimental approaches in retrovirus-mediated expression screening. Int. J. Hematol. 67: 351-359.
11. Dennehy, K. M., F. Elias, S. Y. Na, K. D. Fischer, T. Hünig, and F. Lühder. 2007. Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome. J. Immunol. 178: 1363-1371.
12. Shi, Y., Y. Tohyama, T. Kadono, J. He, S. M. Miah, R. Hazama, C. Tanaka K. Tohyama, and H. Yamamura. 2006. Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis. Blood 107: 4554-4562.
13. Tam, Y. K., G. Maki, B. Miyagawa, B. Hennemann, T. Tonn, and H. G. Klingemann. 1999.Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 10: 1359-1373.
14. Jiang, K., B. Zhong, D. L. Gilvary, B. C. Corliss, E. Hong-Geller, S. Wei, and J. Y. Djeu. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419-425.
15. Suzuki-Inoue, K., G. L. Fuller, A. García, J. A. Eble, S. Pöhlmann, O. Inoue, T. K. Gartner, S. C. Hughan, A. C. Pearce, G. D. Laing, et al. 2006. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107: 542-549.
16. Zhang, J., M. L. Billingsley, R. L. Kincaid, and R. P. Siraganian. 2000. Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J. Biol. Chem. 275: 35442-35447.
17. Songyang, Z., K. L. Carraway, III, M. J. Eck, S. C. Harrison, R. A. Feldman M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng, et al. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536-539.
18. Turner, S. J., N. L. La Gruta, K. Kedzierska, P. G. Thomas, and P. C. Doherty. 2009. Functional implications of T cell receptor diversity. Curr. Opin. Immunol. 21: 286-290.